1.
PDF
reda.moataz.2019
Development of novel nanoparticle based PLK1, EGFR, and PD-L1 targeted therapies for lung cancer
Reda, Moataz ; Yantasee, Wassana
Non-small cell lung cancer (NSCLC) is the deadliest form of cancer and represents nearly a fourth of all cancer related deaths worldwide. Identifying molecular targets an [...]
2019 | Dissertation |
Detailed record - Similar records
2.
PDF
ResearchWeek.2024.Kumar.Pramod
Nanoparticles co-delivering doxorubicin & pd-l1 inhibitor to induce immunogenic cell death and enhance anti-cancer immune response in lung cancer
Kumar, Pramod ; Wallstrum, Alyssa ; Reda, Moataz ; Wang, Ruijie[...]
Non-small cell lung cancer (NSCLC) accounts for one in five of all cancer deaths worldwide. Most patients are diagnosed at advanced stages, resulting in a 5-year survival [...]
2024 | Abstract |
Detailed record - Similar records